Diabetic macular oedema (DMO) is a complication of diabetic retinopathy and is a leading cause of visual loss worldwide. Development of DMO is linked to duration of disease, poor blood glucose control and in type 2 diabetes, the need for insulin.
With the increasing number of people with diabetes increasing worldwide, the prevalence of DMO is likely to increase, with significant implications for patients in terms of health and social care provision.
This CPD course explains clinical features of DMO and treatment options – from laser to anti- VEGF and intravitreal steroids, discussing NICE guidance on treatment and explaining the findings of clinical trials. It promotes an understanding of the condition and an evidence base for treatment to help practitioners advise and refer patients according to current best practice.
See also: Diabetic eyecare – part 3
Australia: 2 T points, self-accredited
New Zealand: 1 CD point, accredited to 31 October 2020
- To recognise and evaluate diabetic eye disease for effective referral.
- Optometrists will have an understanding of the causes and clinical features of diabetic macular oedema, enabling them to make appropriate clinical decisions.
- Optometrists and dispensing opticians will have an evidence-based understanding of treatments for diabetic macular oedema, enabling them to give advice /answer patients’ questions.
How to access
NOTE: ProFile online CPD is currently only available to Specsavers employees with an iLearn account. If you are an external optometrist and would like to be added to our database to receive online CPD material, email email@example.com
Login to iLearn and find the course using the following path:
Available Courses > Optometrist > CPD Online Learning > Diabetes and the eye part 4: New medical treatments for diabetic macular oedema (AU 2T, NZ 1CD)
Both iLearn lessons (article and quiz) must be completed to claim CPD points.
Once you have successfully completed the article and quiz components, an evaluation form will appear within the course that allows you to provide feedback and help Specsavers improve the quality of our CPD.
For technical support, visit the FAQ page.